Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer

Pathobiology

Volumn 71, Issue 3, 2004, Pages 129-136

  Kuniyasu, Hiroki ^a   Sasaki, Takamitsu ^a   Sasahira, Tomonori ^a   Ohmori, Hitoshi ^a   Takahashi, Tadateru ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b HIROSHIMA GENERAL HOSPITAL   (Japan)

Author keywords

Amphoterin; Colon cancer; Macrophages; Metastasis

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CECUM; CELL CONTACT; CELL INFILTRATION; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL MOUSE; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; HMGB1 PROTEIN; HUMANS; IN SITU HYBRIDIZATION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDES, ANTISENSE; SPECIFIC PATHOGEN-FREE ORGANISMS; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 1842455986     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076467     Document Type: Article

References (44)

1. Lissbrant IF, Stattin P, Wikstrom P, Damber JE, Egevad L, Bergh A: Tumor associated macrophages in human prostate cancer: Relation to clinicopathological variables and survival. Int J Oncol 2000;17:445-451.
2. Barbera-Guillem E, Nyhus JK, Wolford CC, Friece CR, Sampsel JW: Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 2002;62:7042-7049.
3. Leek RD, Hunt NC, Landers RJ, Lewis CE, Royds JA, Harris AL: Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 2000;190:430-436.
4. Adini A, Kornaga T, Firoozbakht F, Benjamin LE: Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res 2002;62:2749-2752.
5. Takahashi Y, Bucana CD, Liu W, Yoneda J, Kitadai Y, Cleary KR, et al: Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: Role of infiltrating cells. J Natl Cancer Inst 1996;88:1146-1151.
6. Kennedy S, Duffy MJ, Duggan C, Barnes C, Rafferty R, Kramer MD: Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry. Br J Cancer 1998;77:1638-1641.
7. Etoh T, Shibuta K, Barnard GF, Kitano S, Mori M: Angiogenin expression in human colorectal cancer: The role of focal macrophage infiltration. Clin Cancer Res 2000;6:3545-3551.
8. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, et al: Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002;161:947-956.
9. Pawelek JM: Tumour cell hybridization and metastasis revisited. Melanoma Res 2000;10:507-514.
10. Busund LT, Killie MK, Bartnes K, Seljelid R: Spontaneously formed tumorigenic hybrids of Meth A sarcoma and macrophages grow faster and are better vascularized than the parental tumor. Int J Cancer 2002;100:407-413.
11. Kikkawa H, Imafuku H, Tsukada H, Oku N: Possible role of immune surveillance at the initial phase of metastasis produced by B16BL6 melanoma cells. FEBS Lett 2000;467:211-216.
12. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG: The role of nitric oxide in cancer. Cell Res 2002;12:311-320.
13. Xie K, Fidler IJ: Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev 1998;17:55-75.
14. Hermanowicz A, Gibson PR, Jewell DP: Tumour related inhibition of macrophage chemotaxis in patients with colon cancer. Gut 1987;28:416-422.
15. Funada Y, Noguchi T, Kikuchi R, Takeno S, Uchida Y, Gabbert HE: Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol Rep 2003;10:309-313.
16. Czura CJ, Wang H, Tracey KJ: Dual roles for HMGB1:DNA binding and cytokine. J Endotoxin Res 2001;7:315-321.
17. Parkkinen J, Raulo E, Merenmies J, Nolo R, Kajander EO, Baumann M, et al: Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J Biol Chem 1993;268:19726-19738.
18. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, et al: Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000;405:354-360.
19. Kuniyasu H, Oue N, Wakikawa A, Shigeishi H, Matsutani N, Kuraoka K, et al: Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 2002;196:163-170.
20. Kuniyasu H, Chihara Y, Takahashi T: Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer. Oncol Rep 2003;10:445-448.
21. Kuniyasu H, Chihara Y, Kondo H: Differential effects between amphoterin and advanced glycation end products on colon cancer cells. Int J Cancer 2003;104:722-727.
22. Schmidt AM, Hofmann M, Taguchi A, Yan SD, Stern DM: RAGE: A multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation. Semin Thromb Hemost 2000;26:485-493.
23. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251.
24. Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-195.
25. Morikawa K, Walker SM, Jessup M, Fidler IJ: In vitro selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res 1988;48:1943-1948.
26. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ: Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 1988;48:6863-6871.
27. Kuniyasu H, Yasui W, Shinohara H, Yano S, Ellis LM, Wilson MR, et al: Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am J Pathol 2000;157:1523-1535.
28. Bernal SD, Chen LB: Induction of cytoskeleton-associated proteins during differentiation of human myeloid leukemic cell lines. Cancer Res 1982;42:5106-5116.
29. Kuniyasu H, Oue N, Tsutsumi M, Tahara E, Yasui W: Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3. Clin Cancer Res 2001;7:4067-4072.
30. Wagner JP, Quill DM, Pettijohn DE: Increased DNA-bending activity and higher affinity DNA binding of high mobility group protein HMG-1 prepared without acids. J Biol Chem 1995;270:7394-7398.
31. Shurin MR, Kirkwood JM, Esche C: Cytokinebased therapy for melanoma: Pre-clinical studies. Forum (Genova) 2000;10:204-226.
32. Yang H, Wang H, Tracey KJ: HMG-1 rediscovered as a cytokine. Shock 2001;15:247-253.
33. Rauvala H, Merenmies J, Pihlaskari R, Korkolainen M, Huhtala ML, Panula P: The adhesive and neurite-promoting molecule p30: Analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons. J Cell Biol 1988;107:2293-2305.
34. Melloni E, Sparatore B, Patrone M, Pessino A, Passalacqua M, Pontremoli S: Identity in molecular structure between 'differentiation enhancing factor' of murine erythroleukemia cells and the 30 kD heparin-binding protein of developing rat brain. Biochem Biophys Res Commun 1995;210:82-89.
35. Schraml P, Bendik I, Ludwig CU: Differential messenger RNA and protein expression of the receptor for advanced glycosylated end products in normal lung and non-small cell lung carcinoma. Cancer Res 1997;57:3669-3671.
36. Bacher M, Schrader J, Thompson N, Kuschela K, Gemsa D, Waeber G, et al: Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. Am J Pathol 2003;162:11-17.
37. Karan D, Kelly DL, Rizzino A, Lin MF, Batra SK: Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells. Carcinogenesis 2002;23:967-975.
38. Tomiyasu M, Yoshino I, Suemitsu R, Okamoto T, Sugimachi K: Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance. Clin Cancer Res 2002;8:3755-3760.
39. Albertoni M, Shaw PH, Nozaki M, Godard S, Tenan M, Hamou MF, et al: Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 2002;21:4212-4219.
40. Buckhaults P, Rago C, St Croix B, Romans KE, Saha S, Zhang L, et al: Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 2001;61:6996-7001.
41. Thomsen LL, Miles DW: Role of nitric oxide in tumour progression: Lessons from human tumours. Cancer Metastasis Rev 1998;17:107-118.
42. Morbidelli L, Donnini S, Ziche M: Role of nitric oxide in the modulation of angiogenesis. Curr Pharm Des 2003;9:521-530.
43. Schmidt AM, Yan SD, Wautier JL, Stern D: Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999;84:489-497.
44. Brownlee M: Negative consequences of glycation. Metabolism 2000;49:9-13.